A Phase III, open-label, multi-center, randomized study to investigate the efficacy and safety of MPDL3280A
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
F. Hoffmann-La Roche Ltd
Start Date
February 1, 2015
End Date
January 31, 2020
Administered By
Duke Cancer Institute
Awarded By
F. Hoffmann-La Roche Ltd
Start Date
February 1, 2015
End Date
January 31, 2020